Skip to main content

IVISense GFR 680 Fluorescent Probe (GFR-Vivo)

IVISense GFR 680 (GFR-Vivo) is a NIR fluorescent inulin based probe that enables quantitative assessment of renal Glomerular Filtration Rate (GFR), as an indicator of renal toxicity or injury.

For research use only. Not for use in diagnostic procedures.

Part Number: NEV30000
Part Number: NEV30000
  • Glomerular filtration rate (GFR) is the gold standard in kidney function assessment and is used to determine progression of kidney disease and drug-induced kidney toxicity. One of the most accepted ways to assess GFR is by measuring the rate of disappearance of labeled inulin from the blood; as inulin is completely filtered at the kidneys’ glomeruli (but neither secreted nor reabsorbed by the tubules), this rate of disappearance is directly proportional to GFR.

    Our IVISense GFR 680 fluorescent probe is a labeled form of inulin in a spectral region providing low background and high tissue penetration (ex/em = 670/685 nm) for in vivo applications.

  • Brand
    Fluorescent Agent Type
    Optical Imaging Classification
    Fluorescence Imaging
    Quantity in a Package Amount
    1.0 Units
    Shipping Conditions
    Shipped in Blue Ice
    Unit Size
    1 Vial (10 doses)
    Wave Length
    680 nm


1-4 of 4 Resources
Best practices for designing an effective in vivo fluorescence imaging study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...

In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...

IVISense fluorescent probe selector guide for oncology research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...

Understanding the ‘how’ and ‘why’ of spectral unmixing

In vivo fluorescence imaging displays a very broad utility and has become a well-established modality for functional imaging in...